The fireside chat will discuss topics like:
1. Understanding of biotech industry, industry trends, application of biotech into our daily lives.
2. What are the differences of technology environment among Israel, Singapore, China and the US?
3. How to commercialize research and development?
4. How to deal globally with governments, universities and business relations?
Prof. Dr. Robert S. Marks is a renowned expert and key opinion leader in the field of biosensors. He is a Full Professor at the Ben-Gurion University of the Negev, Israel, at the Department of Biotechnology Engineering. He is presently a Visiting Scientist at the DxD hub at Astar in Singapore.
Robert has previously co-founded Biosensing Technologies Ltd, Biopixel Ltd and Polyrizon Ltd as well as P@bbles whose mission is to introduce new Israeli ventures into Asia.
He is the Editor-in-Chief of a 2007 2-volume Wiley Handbook in Biosensors and Biochips and a 2014 Viral Diagnostics book for virus detection among other books. He also author of 150+ papers (H-index 27) and has several issued patents as well as a dozen filed.
Biosensorix and Eclipse DX aim to provide accurate and convenient diagnostic solutions for rural and urban doctors to save life and save medical costs.
It has developed an point-of-care diagnostic tool that is cheap and easy to use. It can not only be used repeatedly, but also provide quantitative and accurate diagnostic results. In 2016, the global point-of-care diagnostics market was valued at about 19.3 billion US dollars, and Biosensorix aims to account for 8.7 billion of the market. Compared with competitors, their products are affordable, portable and easy to use and can provide quantitative detection.